| 000 | 01665 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513064012.0 | ||
| 264 | 0 | _c19940614 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 024 | 7 |
_a10.1097/00007890-199405150-00010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirano, T | |
| 245 | 0 | 0 |
_aClinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. _h[electronic resource] |
| 260 |
_bTransplantation _cMay 1994 |
||
| 300 |
_a1341-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xpharmacology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisolone _xpharmacology |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aOka, K | |
| 700 | 1 | _aTakeuchi, H | |
| 700 | 1 | _aSakurai, E | |
| 700 | 1 | _aMatsuno, N | |
| 700 | 1 | _aTamaki, T | |
| 700 | 1 | _aKozaki, M | |
| 773 | 0 |
_tTransplantation _gvol. 57 _gno. 9 _gp. 1341-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-199405150-00010 _zAvailable from publisher's website |
| 999 |
_c8183789 _d8183789 |
||